Back to Search
PATRICK MCLAUGHLIN, MD
MD
Cardiovascular Disease Physician
NPI: 1770543878Individual
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
ME91064(FL)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
01074408A(IN)
Research & Publications (20)
Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor.
PMID 18813788·Int J Oncol·2008
7-preclinical
Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.
PMID 18398839·Int J Cancer·2008
8-other
Viral hepatitis vaccination in an opioid treatment program: Hartford, Connecticut, 2002-2005.
PMID 17542453·Public Health Rep·2007
8-other
Predominantly buried residues in the response regulator Spo0F influence specific sensor kinase recognition.
PMID 17350627·FEBS Lett·2007
8-other
Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.
PMID 17273790·Int J Mol Med·2007
8-other
Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor.
PMID 16685459·Int J Oncol·2006
7-preclinical
Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.
PMID 16419087·Glia·2006
4-observational
The use of mutual information in registration of CT and MRI datasets post permanent implant.
PMID 15374537·Brachytherapy·2004
4-observational
Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration.
PMID 14654962·Int J Oncol·2004
7-preclinical
Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines.
PMID 15243630·Cancer Gene Ther·2004
7-preclinical
The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.
PMID 11358833·Cancer Res·2001
7-preclinical
Cancer immunotherapy: insights from transgenic animal models.
PMID 11578916·Crit Rev Oncol Hematol·2001
6-review
The ubiquitin-activating enzyme E1-like protein in lung cancer cell lines.
PMID 10709110·Int J Cancer·2000
8-other
Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy.
PMID 19515511·Int J Radiat Oncol Biol Phys·2010
4-observational
Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost.
PMID 19409729·Int J Radiat Oncol Biol Phys·2010
4-observational
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
PMID 19652063·J Clin Oncol·2009
8-other
Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation.
PMID 19605761·Am J Physiol Regul Integr Comp Physiol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2121 LAKE AVE
FORT WAYNE, IN 46805 - Phone
- (260) 426-5431
Quick Facts
- NPI
- 1770543878
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile